SAN DIEGO, April 01, 2019 (GLOBE NEWSWIRE) -- The Shareholders Foundation, Inc. announces that a lawsuit is pending for certain investors in shares of Davita Inc (DVA).
Investors who purchased shares of Davita Inc (DVA) in February 2015 or earlier and continue to hold any of those NYSE: DVA shares should contact the Shareholders Foundation at email@example.com or call +1(858) 779 - 1554.
On February 1, 2017, a lawsuit was filed against Davita Inc over alleged securities laws violations. The plaintiff alleged that the defendants made false and/or misleading statements and/or failed to disclose that the Company and its senior executives purposefully steered patients into unnecessary insurance plans in order to maximize profits, that the Company was using American Kidney Fund as a vehicle to facilitate these improper practices, that as a result, DaVita's revenues and profits were illegally obtained, that in turn, DaVita lacked effective internal controls over financial reporting, and that as a result of the foregoing, Defendants' statements about DaVita's business, operations, and prospects were false and misleading and/or lacked a reasonable basis. On January 12, 2018, an amended complaint was filed and on March 27, 2018, the defendants filed their motion to dismiss the case. On March 28, 2019, the court denied defendants’ motion to dismiss the case.
Those who purchased Davita Inc (DVA) shares should contact the Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio legal monitoring and a settlement claim filing service, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. The Shareholders Foundation, Inc. is not a law firm. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
Shareholders Foundation, Inc.
+1 (858) 779-1554
3111 Camino Del Rio North
San Diego, CA 92108